Article: New Data and Analyses Demonstrate ABILIFY(R) (Aripiprazole) Effective at Treating Patients With Acute Manic and Mixed Episodes of Bipolar Disorder.

Maintenance of Effect Also Observed with ABILIFY

ABILIFY(R) (aripiprazole) was demonstrated to be effective in treating acute manic and mixed episodes in patients with bipolar disorder, and maintenance of effect for up to 26 weeks was demonstrated, according to new studies and pooled analyses of data from previous studies presented today at the 157th Annual Meeting of the American Psychiatric Association. In addition, the data show that ABILIFY is generally well-tolerated in patients across the studies presented.

"These results provide evidence that ABILIFY is effective in various aspects of bipolar disorder," said Paul Keck, M.D., professor of ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!